[Retracted] Camrelizumab and Apatinib Combined with Radiotherapy Is Effective in Advanced Oligometastatic Non-Small-Cell Lung Cancer

Table 3

Comparison of immune function between the two groups ( ± s).

Group	Observation group (n = 53)		Control group (n = 33)		t
	Before therapy	After treatment	Before therapy	After treatment
CD3^+ (%)	56.36 ± 2.43	59.29 ± 3.31	56.39 ± 2.46	51.89 ± 2.41	10.649	0.015
CD4^+ (%)	28.06 ± 2.75	32.79 ± 2.81	28.13 ± 2.72	25.23 ± 2.66	7.287	0.035
CD8^+ (%)	26.83 ± 1.62	23.63 ± 1.31	26.78 ± 1.66	23.97 ± 1.36	9.468	0.003
CD4^+/CD8^+	1.23 ± 0.32	1.41 ± 0.59	1.25 ± 0.34	1.14 ± 0.52	9.521	0.001
NK cells (%)	16.47 ± 3.32	18.26 ± 3.51	16.39 ± 3.32	14.26 ± 3.14	13.739	<0.001